DAMBKOWSKI CARL (Chief Medical Officer) sold 3.2% of their position (5.50K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $737.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/8/2026ACC: 0001104659-26-092838
Officer· Chief Medical Officer
Since Mar 2026
-5.50K
Net shares
Net seller
$737.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.13K acquired · 9.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.13K
Price / share
$22.86
Trade value
$94.30K
% of position
2.4%
8/5/2026
169.87K→174K
Common Stock
Direct
Shares
−5.50K
Price / share
$134.17
Trade value
$737.93K
% of position
3.2%
8/5/2026
174K→168.50K
Total
Net shares
−1.38K
Net value
-$643.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2026 | M · Option Exercise | +4.13K | $22.86 | $94.30K | 2.4% | 169.87K | 174K |
| Common Stock Direct | 8/5/2026 | S · Sale | −5.50K | $134.17 | $737.93K | 3.2% | 174K | 168.50K |
| Total | −1.38K | -$643.64K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.13K shares
Shares
−4.13K
Strike price
22.86
Held after
110.67K
Exercisable
—
8/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.13K shares | 8/5/2026 | M · Option Exercise | −4.13K | 22.86 | — | 110.67K |